What is it about?
Anejaculation is a rare cause of infertility and adversely affects the general sense of well-being and perception of sexual life satisfaction. Evidence to support effective and noninvasive treatment for this ejaculatory disorder is lacking. This study aimed to evaluate the efficacy and safety of midodrine (alpha(1)-adrenergic receptor agonist) for the treatment of organic anejaculation but not spinal cord injury (SCI).
Photo by SHTTEFAN on Unsplash
Read the Original
This page is a summary of: Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study, International Journal of Impotence Research, May 2009, Springer Science + Business Media, DOI: 10.1038/ijir.2009.19.
You can read the full text:
The following have contributed to this page